The hamster as a model of human visceral leishmaniasis: Progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response

Journal of Immunology

Volumn 166, Issue 3, 2001, Pages 1912-1920

  Melby, P C ^a   Chandrasekar, B ^a   Zhao, W ^a   Coe, J E ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; LYMPHOTOXIN; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME ACTIVITY; GENE EXPRESSION; HAMSTER; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; INFECTION CONTROL; LEISHMANIA DONOVANI; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLENOMEGALY; VISCERAL LEISHMANIASIS;

EID: 0035253601     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.3.1912     Document Type: Article

References (54)

1. Cell-mediated immunity in American visceral leishmaniasis: Reversible immunosuppression during acute infection
2. Absence of γ interferon and interleukin 2 production during active visceral leishmaniasis
3. New perspectives on a subclinical form of visceral leishmaniasis
4. Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity
5. Experimental visceral leishmaniasis: Role of endogenous IFN-γ in host defense and tissue granulomatous response
6. Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis
7. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism
8. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major
9. Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters
10. Wasting and macrophage production of tumor necrosis factor/cachectin and interleukin 1 in experimental visceral leishmaniasis
11. Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis
12. Macrophage deactivating factor and transforming growth factors-β1, -β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ
13. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages
14. Animal models for the analysis of immune responses to leishmaniasis
15. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani
16. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene
17. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
18. Induction of proinflammatory cytokine expression in experimental acute Chagasic cardiomyopathy
19. High sensitivity quantification RNA from gels and autoradiograms with affordable optical scanning
20. Mechanisms regulating macrophage-induced nitric oxide production by spontaneously transformed hamster fibroblasts
21. Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy
22. Profile of human T cell response to leishmanial antigens: Analysis by immunoblotting
23. Humoral immunity and serum proteins in the Syrian hamster
24. Immune response in the hamster: Definition of a novel IgG not expressed in all hamster strains
25. Differential regulation of nitric oxide synthase isoforms in experimental acute chagasic cardiomyopathy
26. Expression and secretion of type β transforming growth factor by activated human macrophages
27. The complex regulation and biology of TNF (cachectin)
28. In vivo cytokine profiles in patients with kala-azar: Marked elevation of both interleukin-10 and interferon-γ
29. Splenic cytokine responses in Indian kala-azar before and after treatment
30. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-γ-stimulated macrophages by induction of tumor necrosis factor-α
31. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine
32. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis
33. Macrophage microbicidal mechanisms in vivo: Reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani
34. Altered immune responses in mice lacking inducible nitric oxide synthase
35. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: Evidence for expansion of distinct helper T cell subsets
36. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β
37. Interleukin 10 production correlates with pathology in human Leishmania donovani infections
38. Potential role for interleukin-10 in the immunosuppression associated with kala azar
39. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation
40. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-β1
41. Anti-TGF-β treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production
42. Transforming growth factor β and immunosuppression in experimental visceral leishmaniasis
43. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide
44. Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo
45. Role and effect of TNF-α in experimental visceral leishmaniasis
46. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation
47. Nitric oxide: A cytotoxic activated macrophage effector molecule
48. Role of nitric oxide synthesis in macrophage antimicrobial activity
49. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes
50. Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions
51. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis
52. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides
53. Suppression of lymphoproliferation by alveolar macrophages in the guinea pig
54. Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/ interferon-γ